IHI.org - A resource from the Institute for Healthcare Improvement
Header Image






Mentor Hospital Registry: MRSA

Campaign Home Page
Mentor Registry Home
Rapid Response Teams Pressure Ulcers
Acute Myocardial Infarction High-Alert Medications
Medication Reconciliation (ADE) Congestive Heart Failure
Central Line Infections MRSA
Surgical Site Infections Surgical Complications
Ventilator-Associated Pneumonia                        Boards on Board


Use this table to quickly find a mentor for the prevention of MRSA with demographics similar to your own, or use 'ctrl+f' in your web browser to search for specific key words on this page.

 

 

Name Location Teaching Urban / Rural Pediatric Bed Size
Beth Israel Medical Center New York, NY Teaching Urban no 1374
Blount Memorial Hospital Maryville, TN no Rural no 194
Centra Health Lynchburg, VA no Urban no 403
Evanston Hospital, Evanston Northwestern Healthcare Evanston, Illinois Teaching Urban no 476
Glenbrook Hospital, Evanston Northwestern Healthcare Glenview, IL Teaching Urban no 143
Highland Park Hospital, Evanston Northwestern Healthcare Highland Park, IL Teaching Urban no 239
Mercy Medical Center Cedar Rapids, IA Teaching Urban no 445
Newark Beth Israel Medical Center Newark, NJ Teaching Urban Adult & Pediatric 567
Parkland Medical Center Derry, NH no Urban no 86
Saint Clare's Health System Denville, NJ no Rural no 260
Veterans Administration Pittsburgh Healthcare System (VAPHS) Pittsburgh, PA Teaching Urban no 146

 

 

Beth Israel Medical Center – New York, NY
Availability Status: Available to answer requests
Licensed Beds: 1374
Teaching / Non-Teaching Status: Teaching
Setting: Urban
Start Date of Intervention Work: August 2006
Mentor Contact Name: Brian Koll, MD
Mentor Contact Email: bkoll@chpnet.org
Mentor Contact Phone: 212-420-2853

 

Additional Information:

Beth Israel Medical Center built on it success with the CLABs and VAP bundles to launch the MRSA bundle.
Because hand hygiene compliance, use of contact precautions, and compliance with CLABs and VAP bundle are 90+%, a system to ensure compliance with the decontamination of the environment and equipment component of the bundle was emphasized through work with environmental services, transporters and radiology.
Active surveillance cultures were also instituted in areas of the hospital where there is a high prevalence of MRSA such as the ICU and also select surgical populations.

There has been a 60% decrease in hospital acquired MRSA infections as well as decreases in the rate of other drug resistant organisms.
Our hospital acquired MRSA rate decreased from 4.0 to 1.0 per 1,000 patient discharges.
Active surveillance has identified that 15% of patients admitted are admitted with MRSA.  These patients are placed on contact precautions.
Environmental cultures from high touch areas are obtained for MRSA after a room is cleaned.  To date, none have been positive.
Control of MRSA and other drug resistant organisms has saved the hospital $1.5 million in avoided costs.

[3/13/07]

 

 

*                *                  *

 

 

Blount Memorial Hospital – Maryville, TN
Availability Status: Available to answer requests
Licensed Beds: 403
Teaching / Non-Teaching Status: Non-teaching
Setting: Rural
Start Date of Intervention Work: January 2004
Mentor Contact Name: MRSA contact - Sherry Hillis, Infection Control Practitioner; Marie Fox, Director of Quality Management
Email: shillis@bmnet.com; mfox@bmnet.com
Mentor Contact Phone: Hillis - 865-980-4860; Fox - 865-981-2476

 

Additional Information:

Aim:  Reduce Methicillin Resistant Staphylococcus aureus transmission in long-term care facility (LTCF) patients admitted to our hospital. This effort involved creating a MRSA project team, creating protocols for handling LTCF patients, targeted MRSA staff & patient education, ongoing communications with LTCF leaders, increased data collection and monitoring, and most important, leadership commitment to support the project.

 

Interventions included:

  • Developed and implemented a new MRSA protocol that involved empiric contact precautions (ECP) and active surveillance cultures (ASC) for patients admitted from LTCF. Treated all patients admitted from LTCF as “MRSA-positive until proven innocent” by placing them automatically on ECP while awaiting results from ASC for MRSA. Required a negative MRSA culture to discontinue ECP.
  • Met with individual LTCF administrators and staff to discuss and educate on MRSA recommendations and new hospital policies. 
  • Conducted daily infection control rounds for surveillance of compliance with ECP and ASC protocols the first six months of the project and intermittently as needed thereafter.  Addressed observed protocol compliance failures immediately by meeting with clinical supervisors and their respective unit staff within 24 hours of occurrence.  Conducted targeted follow-up surveillance on all reported compliance failures.
  • Purchased additional isolation carts and revised isolation cart package contents to more efficiently and economically provide care for patients in ECP.
  • Implemented a concomitant hand hygiene program throughout the hospital.
  • Developed new easy-to-understand patient and family educational brochures on MRSA and ECP.

Results:

  • The HO-MRSA incidence trend moved from an upward quarterly trend (+0.048) to a sustained downward trend (-0.024)

  • The HO-MRSA rate has decreased 50%

  • The MRSA reportable isolate rate has decreased 75%

  • Average length of stay among hospitalized LTCF residents has decreased by 2.2 days

[4/18/08]

 

 

*                *                  *

 

 

Centra Health – Lynchburg, VA
Availability Status: Available to answer requests
Licensed Beds: 403
Teaching / Non-Teaching Status: Non-teaching
Setting: Urban
Start Date of Intervention Work: October 2006
Mentor Contact Name: Kathy Bailey, RN, CIC
Mentor Contact Email: kathy.bailey@centrahealth.com
Mentor Contact Phone: 434-947-7780

 

Additional Information:

In 2004, Centra Health realized a 28% reduction in critical care MRSA infections by implementing contact precautions, appropriate disinfection and hand hygiene and selectively performing active surveillance cultures (ASC) on admissions noted to be at high risk for MRSA. In October 2006, we made the decision to do ASC on ALL admissions to our medical intensive care unit to further reduce infections and we will add our surgical intensive care unit in May 2007.

Our MRSA infection rate has been 0.00 in our medical intensive care unit for 5 consecutive months

[4/30/07]

 

 

*                *                  *

 

 

Evanston Hospital, Evanston Northwestern Healthcare—Evanston, Illinois
Availability Status: Available to answer requests
Licensed Beds:  476
Teaching/ Non-Teaching Status:  Teaching
Setting:  Urban
Start Date of Intervention Work: August 2005
Mentor Contact Name: Donna M. Hacek, MT (ASCP)
Mentor Contact Email: dhacek@enh.org
Mentor Contact Phone: 847-570-1731

 

Additional Information:

The Evanston Hospital, Evanston Northwestern Healthcare MRSA Prevention Program has been able to design and deploy a universal surveillance program for detecting patients carrying MRSA

We were able to roll out the program with excellent compliance for MRSA admission screening within a few months of the program's beginning.

The successful program rapidly detected new patients with MRSA on admission so that they could be appropriately placed in contact isolation to prevent MRSA being spread to other patients, thus preventing infections in patients not already harboring MRSA.

The program also successfully decolonized the newly recognized MRSA patients so that they did not return in the future with a MRSA infection.

The MRSA Prevention Program saved enough money on the prevented MRSA infections that it paid for itself in the first year of operation.


By the end of the first year there was a sustainable rate of performing surveillance on all new admissions exceeding 90%.

In the first year there was a 50% reduction of MRSA nosocomial bloodstream infections hospital-wide.

In the first year there was a 75% reduction of MRSA nosocomial resipratory infections hospital-wide.

By the end of the first year the cost of the program was $600,000 and the excess healthcare costs avoided from preventing MRSA infection were determined to be cost-saving to the organization by our finance department.
[3/13/07]

 

 

*                *                  *

 

 

Glenbrook Hospital, Evanston Northwestern Healthcare—Glenview, IL
Availability Status: Available to answer requests
Licensed Beds:  143
Teaching/ Non-Teaching Status:  Teaching
Setting:  Urban
Start Date of Intervention Work: August 2005
Mentor Contact Name: Donna M. Hacek, MT (ASCP)
Mentor Contact Email: dhacek@enh.org
Mentor Contact Phone: 847-570-1731

 

Additional Information:

The Glenbrook Hospital, Evanston Northwestern Healthcare MRSA Prevention Program has been able to design and deploy a universal surveillance program for detecting patients carrying MRSA

We were able to roll out the program with excellent compliance for MRSA admission screening within a few months of the program's beginning.

The successful program rapidly detected new patients with MRSA on admission so that they could be appropriately placed in contact isolation to prevent MRSA being spread to other patients, thus preventing infections in patients not already harboring MRSA.

The program also successfully decolonized the newly recognized MRSA patients so that they did not return in the future with a MRSA infection.

The MRSA Prevention Program saved enough money on the prevented MRSA infections that it paid for itself in the first year of operation.
By the end of the first year there was a sustainable rate of performing surveillance on all new admissions exceeding 90%.

In the first year there was a 50% reduction of MRSA nosocomial bloodstream infections hospital-wide.

In the first year there was a 75% reduction of MRSA nosocomial resipratory infections hospital-wide.

By the end of the first year the cost of the program was $600,000 and the excess healthcare costs avoided from preventing MRSA infection were determined to be cost-saving to the organization by our finance department.
[3/13/07]

 

 

*                *                  *

 

 

Highland Park Hospital, Evanston Northwestern Healthcare - Highland Park, IL
Availability Status: Available to answer requests
Licensed Beds:  239
Teaching/ Non-Teaching Status:  Teaching
Setting:  Urban
Start Date of Intervention Work: August 2005
Mentor Contact Name: Donna M. Hacek, MT (ASCP)
Mentor Contact Email: dhacek@enh.org
Mentor Contact Phone: 847-570-1731

 

Additional Information:

The Glenbrook Hospital, Evanston Northwestern Healthcare MRSA Prevention Program has been able to design and deploy a universal surveillance program for detecting patients carrying MRSA

We were able to roll out the program with excellent compliance for MRSA admission screening within a few months of the program's beginning.

The successful program rapidly detected new patients with MRSA on admission so that they could be appropriately placed in contact isolation to prevent MRSA being spread to other patients, thus preventing infections in patients not already harboring MRSA.

The program also successfully decolonized the newly recognized MRSA patients so that they did not return in the future with a MRSA infection.

The MRSA Prevention Program saved enough money on the prevented MRSA infections that it paid for itself in the first year of operation.
By the end of the first year there was a sustainable rate of performing surveillance on all new admissions exceeding 90%.

In the first year there was a 50% reduction of MRSA nosocomial bloodstream infections hospital-wide.

In the first year there was a 75% reduction of MRSA nosocomial resipratory infections hospital-wide.

By the end of the first year the cost of the program was $600,000 and the excess healthcare costs avoided from preventing MRSA infection were determined to be cost-saving to the organization by our finance department.
[3/13/07]

 

 

*                *                  *

 

 

Mercy Medical Center – Cedar Rapids, IA
Availability Status: Available to answer requests
Licensed Beds: 445
Teaching / Non-Teaching Status: Teaching
Setting: Urban
Start Date of Intervention Work: September 2003
Mentor Contact Name: Stacy DeMoss
Mentor Contact Email: sdemoss@mercycare.org
Mentor Contact Phone: 319-398-6696

 

Additional Information:

• Developed protocols for screening patients upon admission to identify MRSA carriers. Educated staff about the rising MRSA prevalence in the community, the anticipated benefits of the screening program, and how to handle the anticipated increase in isolation cases on each unit.

• Changed the contact isolation protocol to include gown, gloves, and mask as the personal protective equipment required for every person entering the room, visitors included.   Every person who enters a patient's room performs hand hygiene before coming in contact with the patient and then performs hand hygiene again before exiting the room.
 
• Nursing home residents or persons transferred from acute care facilities are placed into contact isolation and nasal swabs are collected. The patient remains in contact isolation until nasal swab is ruled negative for MRSA.  Persons with skin and/or soft tissue infections are also placed into contact isolation, the wound opened by the physician, if appropriate, and a culture collected to rule out MRSA.

• Beginning in January 2005, total joint patients have been screened for MRSA nasal carriage during pre-surgical teaching and evaluation sessions.  Cardiologists and vascular surgeons have now agreed to use the total joint protocol for persons scheduled for CABG or ICD or pacer implants. This program is under development.
 
• Every admission is reviewed to ensure that cultures are collected and appropriate isolation precautions are established.

• Support of the nurse managers has been important to the initiation and maintenance of the change.  Members of the patient care team, including physical therapists, speech and occupational therapists and social workers, are staunch supporters of the process and assist visitors to understand the purpose of the precautions and encourage visitor involvement in reducing the spread of multidrug-resistant organisms.

• Prevention costs money.  Infections cost money and increase morbidity and mortality.

Reduction in MRSA HCAI rates from an average of 0.67 (per 1000 pt days) from January 2004 through December 2005 to 0.33 (per 1000 pt days) from January 2006 through March 2007.
[6/5/07]

 

 

*                *                  *

 

 

Newark Beth Israel Medical Center – Newark, NJ
[Adult & Pediatric Mentor]

Availability Status: Available to answer requests
Licensed Beds:  567
Teaching/ Non-Teaching Status:  Teaching
Setting:  Urban
Start Date of Intervention Work: August 2005
Mentor Contact Name: Jeremias L. Murillo, MD, Hospital Epidemiologist
Mentor Contact Email: jmurillo@sbhcs.com
Mentor Contact Phone: (973) 926-7329

 

Additional Information:

Newark Beth Israel Medical Center is a 600-bed tertiary care medical center that serves both an inner city (predominantly African-American) and a suburban patient population. In recent years, we've had a significant increase in the number of admitted patients colonized with MRSA. This has resulted in an overall increase in both community-associated and health care-associated MRSA infections.

In our neonatal intensive care unit (NICU), babies were being admitted colonized with MRSA at birth and we have shown that mothers were also colonized at the time of delivery. Because of these findings, we instituted MRSA screening for nasal colonization for all admissions to our NICU.

The systematic process for implementation included the following:

The problem identified was the increasing incidence of MRSA infections in premature infants in July 2005. A team was formed consisting of representatives from Neonatology, Nursing, Microbiology Laboratory, Housekeeping, Infection Control and Epidemiology. The purpose of the team was to implement infection control measures including surveillance, identification of infected and colonized patients, use of cohort methods and isolation techniques, intensive environmental sanitation and health care worker education.

The steps in the process were:

• Verification of the diagnosis and confirmation of MRSA infection in the babies
• Surveillance and search for additional infected cases
• Use of isolation techniques to prevent the spread of MRSA to other babies
• Convening the team to address the problem and sustain the control measures
• Initiating aggressive environmental cleaning procedures
• Testing other babies for nasal colonization with MRSA
• Cohorting of infected and colonized babies
• Discovering that babies were being admitted already colonized with MRSA
• Initiating MRSA screening for all admissions and decolonizing positive babies with topical mupirocin
• MRSA screening of health care workers with direct patient contact (one-time only)
• Weekly team meetings to monitor results
• Introducing state-of-the-art MRSA screening using PCR-based technology
• Repeating the risk assessment to identify the next unit to apply the methodology
• Duplicating the same methodology in the adult ICU in September 2006 

Lessons learned: 

• Perform a risk assessment for MRSA in your own institution to identify the high-risk areas. (We found variations from unit to unit.)

• Develop a methodology to identify the previously unrecognized cases of MRSA colonization being admitted to the hospital.

To date, we have identified 22 babies positive at birth. As a result of our ability to identify and decolonize positive babies, we have not seen a single MRSA infection in our NICU for 15 consecutive months. The previous year, we had 20 MRSA infections.

We duplicated this process in our adult ICU in September 2006 and we have seen a colonization rate of 21% on all admissions or transfers to the ICU. Since we instituted admission screening, we have not seen a single MRSA infection in 6 months of surveillance.
[4/7/07]

 

 

*                *                  *

 

 

Parkland Medical Center - Derry, NH
Availability Status: Available to answer requests
Licensed Beds:  86
Teaching/ Non-Teaching Status:  Non-Teaching
Setting:  Urban
Start Date of Intervention Work: October 2003
Mentor Contact Name: Karen Cozzens, RN, MSN, CIC
Mentor Contact Email: Karen.Cozzens@HCAhealthcare.com
Mentor Contact Phone: 603-421-2296

 

Additional Information:

• Parkland Medical Center began its fight against MRSA in October 2003 with a strong hand hygiene campaign emphasizing the effectiveness and convenience of alcohol hand rubs.  This campaign also focused on the correct choice and placement of hand rubs and hand hygiene monitoring.

• Strong partnerships and collaboration have been formed with environmental services staff, the important role of cleaning and disinfection of the environment in controlling and preventing all HAI has been emphasized, and staff have been empowered in their role.

• Communication (immediate verbal, electronic, color-coded wristbands) and collaboration with lab, ancillary services, nursing, & admitting ensures control measures are put into place quickly when a + MRSA culture is identified to prevent the spread of infection to others.

• VAP and central line bundles were implemented in 2005 & 2006.
 
• Device bundle compliance, vent weaning, and discontinuation of central lines and foleys are a priority and are monitored during daily multidisciplinary patient care rounds

• Parkland Medical Center's alcohol hand rub usage increased 170% in 2003 after a hand culture "experiment" started the hand hygiene campaign.  Usage has remained steady since then.

• The healthcare-acquired MRSA rate has decreased for 3 years in a row to 0.6 cases per 1000 patient days in 2006

• There have been NO cases of ventilator-associated pneumonia since September 2005.
• There have been NO cases of central line-related blood stream infections since November 2005.
• In addition, the healthcare-acquired C. difficile rate decreased 33% in 2006 as a result of excellent implementation of hand hygiene and contact precaution measures by clinical staff and excellent environmental cleaning & disinfection.

[4/7/07]

 

 

*                *                  *

 

 

Saint Clare's Health System – Denville, NJ
Availability Status: Available to answer requests
Staffed Beds: 260
Teaching / Non-Teaching Status: Non-Teaching
Setting: Rural
Start Date of Intervention Work: January 2006
Mentor Contact Name: Norma Atienza, RN Director Clinical Quality and Epidemiology and Laura Anderson, RN, Nurse Epidemiologist
Mentor Contact Email: natienza@saintclares.org; landerson@saintclares.org
Mentor Contact Phone: 973-625-6597; 973-625-6598

 

Additional Information:

St. Clare's Health System has one Infection Control department for three acute care campuses of varying sizes (Denville:  260 staffed beds; Dover: 50; and Sussex: 41.)  In 2003, Saint Clare’s infection rate for MRSA was 0.84. With the incoming of a new epidemiology director and staff in 2004, we looked at new ways to decrease the transmission of MRSA as well as our health care acquired infections. MRSA colonized patients had previously not been isolated so we began isolating all MRSA positive patients. In addition to standard precautions, contact precautions were also implemented.

Hand Hygiene Campaign:  Compliance rate to hand washing was 72 percent in 2004.  We heightened our hand washing awareness in 2005 and began a hand hygiene campaign. Monthly hand hygiene audits were done by actual observation. A data collection tool was revised (see appendix) and unit based “hand washing secret agents” were asked to perform 20 observations a month in a patient care unit. Secret agents are an interdisciplinary mix including RNs, LPNs, nursing assistants, unit secretaries, respiratory therapists and physical medicine staff. Results were sent to the epidemiology department for data analysis and reporting. Concurrent corrective actions were implemented for departments with low compliance rates. Compliance rate went up to 82 percent by the end of 2005. Tickets were designed in 2007 to be given to those that are caught not washing their hands as a gentle reminder to be compliant. Hand hygiene compliance was also integrated in the employee’s annual evaluation. Additional alcohol hand gel dispensers were also installed in high traffic areas to increase compliance.

Environmental cleaning:  In 2005 and 2006 all efforts continued with collaboration and emphasis on environmental services. All discharge units are terminally cleaned including changing cubical curtains for all patients that were on isolation during their stay. Environmental Staff were also evaluated on actual cleaning and went through a rigorous educational session on the importance of a clean environment to the prevention and control of infection. Policies were revised appropriately.

Infection Control Liaison:  In 2006, we began our Infection Control Liaison Program. Staff members from the nursing units were assigned to be the “Infection Control Expert” on their units. They meet regularly with the Infection Control Practitioners to review unit specific goals and health care acquired infection rates. They serve as the eyes and ears of the ICPs in the units and also as an infection control resource for their co-staff. New ideas are discussed and shared and contribute to the development of new policies and protocols.

Flagging Positive Cases:  In 2004, we worked with our IT and Admitting Departments to have a system of identifying positive cases of not only MRSA but all MDRO patients including C. Diff when they are readmitted into our acute care facilities. These are the cases that were not cleared of infection before discharge. If they are re-admitted, Admitting Staff must review the MDRO/C. Diff status on Admission Face Sheet and must notify the unit to ensure the patient is properly and timely isolated.

Education:  With the heightened awareness of MRSA, especially in the community, we have been providing multiple educational sessions on the prevention and control of infections, especially MRSA. Isolation protocols and practices are reviewed to our nursing staff in different scenarios, informal, formal, group, or one to one sessions. MRSA education is also expanded to our visitors and to the community that we serve.

Screening:  2007 brought mandatory MRSA nasal screening in New Jersey. By state law, all hospitals were to begin MRSA nasal screenings in a designated high risk area (such as the ICU). At Saint Clare’s, we expanded our screening population to many high risk populations. All nursing home, hemodialysis inpatients and all past positive MRSA patients are being screened. In early 2007 we identified an increase in our MRSA orthopedic surgical site infections so all pre-op orthopedic patients are also screened pre-operatively as well as all surgical patients that are being discharged to a nursing home or rehabilitation facility.  The program was rolled out in our three acute care facilities. Standing orders for MRSA nasal screening were developed. Rapid PCR testing began November 15, 2007 (initially screens were done via culture plating). In 2007, 1105 patients were screened with 123 positive (11.1 percent positive rate). By the end of February 2008, 656 patients have been screened with 131 positive (20 percent positive rate). All positive patients are immediately isolated and placed on contact precautions.

We are continuously reviewing and evaluating our program goals and outcomes. Through active participation via conferences and webinars with APIC, IHI, CDC and other related associations, new ideas and innovations are developed to further improve our prevention strategies.


Hand hygiene compliance has shown great improvement over the years and system wide, Saint Clare’s had a compliance rate of 91.4 percent in 2007. 

Through all our efforts, MRSA hospital acquired infection rates have declined from 0.84 in 2003, 0.54 in 2004, 0.48 in 2005, and 0.35 in 2006 to 0.29 in 2007 – an improvement of 35 percent over 5 years.
[5/1/08]

 

 

*                *                  *

 

 

Veterans Administration Pittsburgh Healthcare System (VAPHS)–Pittsburgh, PA
Availability Status: Available to answer requests
Licensed Beds:  146
Teaching/ Non-Teaching Status:  Teaching
Setting:  Urban
Start Date of Intervention Work: August 2001
Mentor Contact Name: Candace Cunningham, RN, MRSA Coordinator
Mentor Contact Email: candace.cunningham@med.va.gov
Mentor Contact Phone: (412) 688-6000, Ext. 815612

 

Additional Information:

(a) August 2001 to June 2005: An industrial model (Toyota Production System or TPS) was piloted on a surgical specialty nursing unit and surgical intensive care unit to enable the staff to comply with evidence-based precautions (SHEA guidelines) to prevent MRSA HAIs. TPS-trained mentors and team leaders worked with staff to standardize routines and create system changes that enabled them to implement strict hand hygiene, active surveillance and contact isolation precautions with dramatic reductions in MRSA HAIs in the two pilot units in the 125 bed acute care facility (VAPHS-UD).

(b) July 2005: VAPHS initiated hospital-wide implementation of hand hygiene, active surveillance and appropriate contact isolation precautions in its 125 bed acute care and 275 bed long term care facility.

(c) July 2005: Clinical and administrative leaders and staff representatives attend Positive Deviance (PD) workshop. PD is an approach to behavioral and cultural transformation from within an organization which enables the staff and patients to assume true ownership of the problem (MRSA HAIs) and solutions.

(d) August 2005: Orders for active surveillance culture (nares swabs) "hard wired" in to EMR on every patient on admission and discharge. Culture results reported to nursing units daily. Performance data (nares swabbing rates, MRSA transmission and infection rates) reported to nursing units weekly.

(e) August through November 2005: Discovery and action dialogs with 500 staff and patients in the two facilities to discuss their practices and ideas on how to prevent MRSA transmissions and associated infections. Volunteers emerge to work on the problem.

(f) September 2005: Weekly 15 minute stand-up briefings in each nursing unit initiated. Staff reports their performance data, successes and improvement opportunities and identify barriers which clinical and administrative leaders attending the briefings can help eliminate.

(g) August 2006: MRSA status of patients shared with support services where staff create ways of applying transmission-based precautions for MRSA colonized and infected patients.

(h) November 2006: Patients engaged in "Partners in Your Care" (Univ. Penn/Steris) to learn about the importance of hand hygiene for themselves, their families and their care givers.

(i) Oct. 2006: VAPHS system-wide celebration of success in achieving goal of 50% reduction in MRSA HAIs.

January 2007: VAPHS reports system wide: >90% nares swabbing rates, 60% increase in compliance with hand hygiene and contact isolation precautions and 50% reduction in MRSA HAI's.

[3/13/07]